Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BICRA like chromatin remodeling complex associated protein (BICRAL) is a protein-coding gene product that serves as a core component of the SWI/SNF chromatin remodeling complex, specifically the non-canonical GBAF subcomplex[6][10]. Chromatin remodeling complexes alter the structure of chromatin to regulate access to DNA for transcription, replication, and repair. BICRAL participates in protein binding and gene regulation processes essential for cellular differentiation and tissue-specific gene expression. It is expressed widely in mammalian tissues and is highly conserved across species, with alternative names reflecting its discovery and characterization by various research groups[4][9][12]. Unlike other SWI/SNF complex components or interaction partners like BRD4, BICRAL is not a receptor, enzyme, or known therapeutic target, and no drugs are currently recognized to modulate its function directly[6][10]. If further information is required regarding its involvement in disease or interaction with drugs, it will be necessary to consult more detailed functional genomics or proteomics databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BICRA like chromatin remodeling complex associated protein (BICRAL).